共 20 条
[1]
MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study. Kohara,Fujisawa,Ando,et al. Stroke . 2003
[2]
Polymorphisms in cystathionine beta-synthase and methylenetetrahydrofolate reductase genes as risk factors for cerebral vascular disease. Gutierrez JI,Perez F,Tamparillas M,et al. Medicina Clinica . 2005
[3]
Homocysteine and cerebral infarction in finnish male smokers. Fallon UB,Virtamo J,Young I,et al. Stroke . 2003
[4]
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the Northern Manhattan Study. Sacco RL,Anand K,Lee HS,et al. Stroke . 2004
[5]
Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. Bos MJ,Goor ML,Koudstaal PJ,et al. Journal of Neurology . 2005
[7]
Hyperhomocysteinemia in acute cerebral infarction. Millan-Guerrero RO,Vazquez C,Isais-Aguilar L,et al. Gaceta Medica de Mexico . 2003
[8]
Homocysteine levels in patients with stroke:clinical relevance and therapeutic implications. Hankey GJ,Eikelboom JW. CNS Drugs . 2001
[9]
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o. Dusitanond P,Eikelboom JW,Hankey GJ,et al. Stroke . 2005
[10]
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP)randomized controlled trial. Toole JF,Malinow MR,Chambless LE,et al. The Journal of The American Medical Association . 2004